Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesis

Biochemistry
L Y LiA Yayon

Abstract

Using modeling of heparin-fibroblast growth factor interactions, we replaced four basic residues of basic fibroblast growth factor (FGF-2) with neutral glutamine residues by site-specific mutagenesis to give the mutants K128Q, K138Q, K128Q-K138Q, R129Q, K134Q, and R129Q-K134Q. The FGF mutants were characterized for their receptor and heparin binding affinities, mitogenic and cell proliferation activities, and their ability to induce plasminogen activator (PA) production and in vitro angiogenesis by cultured endothelial cells. Heparin binding properties and biological activities of the three mutants involving R129 and K134 remained essentially unchanged; however, significant changes for three mutants involving K128 and K138 were found. The KD values for heparin binding for K128Q and K138Q mutants were increased about 10-fold, and that for the K128Q-K138Q double mutant was increased by about 100-fold. The mutant K128Q-K138Q required a 10-fold higher concentration of heparin to promote binding to heparan sulfate proteoglycan (HSPG)-deficient CHO cells transfected with fibroblast growth factor receptor-1 (FGFR1) or to induce DNA synthesis in HSPG-deficient myeloid cells transfected with FGFR1. Binding affinities of the mutants to c...Continue Reading

References

Jan 1, 1992·Advances in Cancer Research·C Basilico, D Moscatelli
Jan 1, 1991·Annals of the New York Academy of Sciences·A SeddonP Böhlen
Apr 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·A E ErikssonB W Matthews
Apr 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·J D ZhangS R Sprang
Jan 1, 1991·Annual Review of Biochemistry·L Kjellén, U Lindahl
Oct 1, 1991·Current Opinion in Cell Biology·J D Esko
Mar 8, 1991·Cell·E Ruoslahti, Y Yamaguchi
Jun 1, 1991·The Journal of Cell Biology·C Nathan, M Sporn
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A BairdR Guillemin
Jan 1, 1988·Journal of Medicinal Chemistry·K Taira, S J Benkovic
Apr 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·I VlodavskyM Klagsbrun
Sep 1, 1986·Journal of Cellular Physiology·D Gospodarowicz, J Cheng
Dec 11, 1980·Nature·J Folkman, C Haudenschild
Nov 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·D GospodarowiczP Böhlent
Jan 1, 1993·Archives of Biochemistry and Biophysics·D B VolkinC R Middaugh

❮ Previous
Next ❯

Citations

Jun 1, 1996·Developmental Dynamics : an Official Publication of the American Association of Anatomists·M ChoyP B Armstrong
Nov 18, 1998·Current Opinion in Structural Biology·S FahamD C Rees
Jul 2, 2009·Molecular & Cellular Proteomics : MCP·Alessandro OriDavid G Fernig
Jul 21, 1998·Journal of Biomolecular Structure & Dynamics·K LamP K Qasba
May 31, 2008·Journal of Biochemistry·Karsten RoseJosef Krieglstein
Jan 1, 2012·Journal of Materials Chemistry·Justin T KoepselWilliam L Murphy
Mar 7, 2006·Seminars in Ophthalmology·Linda J Metheny-Barlow, Lu-Yuan Li
Mar 4, 2005·Drug Delivery·David D Hile, Michael V Pishko
Jan 23, 2016·PeerJ·Quentin M NunesDavid G Fernig
May 26, 2007·Neurochemistry International·Karsten RoseJosef Krieglstein
May 19, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jianjun GuanWilliam R Wagner
Jan 13, 2005·International Journal of Cancer. Journal International Du Cancer·Yunguang TongJian Ding
Oct 27, 2011·Advanced Materials·Gregory A HudallaWilliam L Murphy
Jul 21, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sébastien A GittensHasan Uludag
May 3, 2005·Cytokine & Growth Factor Reviews·Moosa MohammadiOmar A Ibrahimi
Jul 9, 1997·Biochemical and Biophysical Research Communications·T AsaiT Muramatsu
Jan 13, 1997·Biochemical and Biophysical Research Communications·S SuzuK Motoyoshi
Dec 24, 2002·The Journal of Biological Chemistry·Antonio FacchianoMaurizio C Capogrossi
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bart C KuenenGiuseppe Giaccone
Apr 11, 1997·The Journal of Biological Chemistry·F SoncinR Shapiro
Jun 9, 1999·International Journal of Cancer. Journal International Du Cancer·Y ZhaiL Y Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.